Jianping Lin

机构：Chinese Academy of Sciences, Nankai University, Purdue University West Lafayette, Biodesigns (United States), Tianjin Institute of Industrial Biotechnology, State Key Laboratory of Chemical Engineering, State Key Laboratory of Medicinal Chemical Biology · ORCID：0000-0001-6974-0072

发表论文 170 篇 · 总被引 5200 次 · h-index 40

代表论文

Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers (2024 · Journal of Clinical Investigation · 被引 15)
NiCo LDH deposited on novel LIG-derived substrates with controllable morphology for high-performance symmetric supercapacitors (2025 · Journal of Alloys and Compounds · 被引 10)
Discovery and evaluation of novel SHIP-1 inhibitors (2024 · Bioorganic & Medicinal Chemistry · 被引 8)
Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases (2024 · Journal of Medicinal Chemistry · 被引 5)
Ti-Doped CuGaTe 2 as a High-Performance Thermoelectric Material: Enhancing Thermoelectric Properties through N-Type Doping (2025 · ACS Applied Electronic Materials · 被引 4)
Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy (2024 · European Journal of Medicinal Chemistry · 被引 2)